T
he clinical course of patients with acute exacerbations of underlying COPD and hypercapnic respiratory failure has not been fully characterized. Most clinicians are aware that these patients with hypercapnic respiratory failure may require several days of intensive medical therapy before recovery, and that not all patients will require intubation. Prior studies [1] [2] [3] [4] [5] [6] in this area have primarily focused on intubation rates or mortality, with scant attention to the time course for resolution of hypercapnia. Early reports placed mortality rates in the 20 to 35% range, and this has declined to the 14 to 24% range in later years. [7] [8] [9] [10] [11] [12] More recently, attention has focused on admission parameters including underlying functional status, nutrition, severity of disease with or without comorbid conditions, and baseline hypercapnia as possible predictors of eventual outcome. 11, [13] [14] [15] [16] These studies do not address the time course to resolution or failure of medical therapy. The major dilemma involves those patients with severe underlying COPD, in whom response may be slow with the options of intubation and mechanical ventilation tempered by an increased likelihood of prolonged intubation and/or mortality. Menzies and colleagues 14 found that 58% of their COPD patients were intubated for Ͼ 14 days, and 40% of that group were never weaned from mechanical ventilation.
Better characterization of the response to therapy would provide additional insight in the management of these patients, especially with respect to expectations for recovery or the need for assisted ventilation. In addition, with noninvasive ventilation gaining increasing acceptance as initial therapy, an understanding of the expected time frame for resolution of hypercapnic respiratory failure in COPD patients may help further define the role of noninvasive ventilation.
Therefore, the clinical course of COPD patients with hypercapnic respiratory failure admitted to our medical ICU (MICU) was reviewed over a 5-year period. The time frames for the resolution of a patient's acute exacerbation or time to intubation were the major focus of our review.
Materials and Methods
Since 1989, all patients admitted to our MICU have been entered into a computerized database using the Decentralized Hospital Computer Program. Collected data include information on admitting and discharge diagnoses; admitting APACHE II (Acute Physiology and Chronic Health Evaluation) II scores; invasive procedures, including intubation; duration of mechanical ventilation; complication; length of stay; and mortality. The system has laboratory data archived since the mid-1980s. Since 1994, progress notes with an automatic time and date designation have been available for review.
This database was screened for all patients with a discharge diagnosis of COPD exacerbation between January 1, 1990, and December 31, 1994. From this list, the admission arterial blood gas (ABG) analysis for their hospitalization was obtained, focusing on patients with a respiratory acidosis (defined as a Paco 2 Ն 50 mm Hg and pH Յ 7.35). Pulmonary function tests (PFTs) obtained at our pulmonary function laboratory within 1 year of their hospitalization were reviewed. Patients better characterized as having asthma based on PFTs (FEV 1 /FVC within 10% of predicted and a bronchodilator response defined as Ն 200 mL and Ն 12% improvement in FEV 1 ) or a subsequent clinical diagnosis of asthma were eliminated from further analysis. Additional chart review also confirmed that these patients fulfilled American Thoracic Society guidelines for the diagnosis of COPD. 17 Patients treated with noninvasive ventilation during this time period were excluded from analysis.
A chart review was conducted of those patients identified with COPD and hypercapnic respiratory failure. This included a review of their laboratory data (ABG analyses, chemistries, theophylline levels), chest radiograph (CXR) reports, orders, treatment records, and progress notes. The Decentralized Hospital Computer Program system allowed for the bulk of this data to be extracted by computer query. Precise times could be identified from laboratory report times and were used to generate a time frame for the response to therapy. Medical therapy consisted of inhaled ␤ 2 -agonists (predominantly albuterol, rarely metaproterenol), anticholinergic agents (predominantly ipratropium bromide, rarely inhaled atropine), systemic steroids (methylprednisolone or prednisone), and antibiotics. Theophylline was not routinely added to therapy, but was usually continued if used on an outpatient basis unless there was concern about toxicity. Treatment varied widely with respect to method of delivery, dose, and frequency of treatments, but was otherwise uniform with respect to the class of agents utilized. The decision to intubate was at the discretion of the treating physicians. Although no standardized guidelines were in effect, patients usually met standard criteria for intubation (progressive hypoxemia or hypercapnia, imminent respiratory arrest or respiratory failure, progressive obtundation, etc). 18 -20 Review of progress notes, treatment records, and laboratory reports verified the timing of specific events. The onset of treatment was defined by the time of the initial ABG. This was considered an entry condition by which these patients could be designated as presenting with hypercapnic respiratory failure. This initial ABG was obtained with the patient breathing room air or supplemental oxygen. This uniformly occurred in the emergency department, with a few patients identifed during outpatient clinic visits. If patients were intubated on presentation, the time to intubation was designated as 15 min. Review of emergency department record sheets verified that this was a reasonable assumption from time of presentation to intubation. In this medical center, nearly all intubations are performed by the Anesthesiology Service and documented in a separate note. This allowed another source of verification of the time of intubation. Nursing notes and the ICU flow sheet were other sources that allowed verification of specific events. To further corroborate event times, the immediate postintubation ABG provided another source to determine the time of intubation. The general practice in our institution is to obtain a postintubation ABG within 30 min of intubation. All of these sources of information allowed designation of an accurate time for intubation, usually within 1 h of its occurrence. Resolution of hypercapnic respiratory failure was defined as improvement in pH to Ն 7.35. There were no standard time frames for the measurement of serial ABGs. On average, four ABGs were available for review within the first 24 h of admission. These ABG results were placed into time slots to allow generation of a time response (or time to intubation) curve. The time slot designations were at admission; at 1, 2, and 4 h from presentation; and then every 4 h. Values had to be within 2 h of the time slot (except for hours 1 and 2). In addition, a precise time from time of presentation to the time to intubation or resolution was also identified from chart review. The data were analyzed in aggregate, by outcome (medical therapy or intubated) and within designated subgroups based on the initial pH. Other information evaluated included APACHE II scores, laboratory studies, CXR results, and all-cause 30-day mortality.
Statistical analysis was performed using t tests, repeatedmeasures analysis of variance (ANOVA), post hoc analysis with the Newman-Keuls method, and 2 tests with the assistance of statistical software (Primer of Biostatistics, version 4.0; McGrawHill, Inc; New York, NY).
Results
During the 5-year study period, a total of 295 episodes of COPD and respiratory failure were treated in our MICU. Two additional patients were determined to have asthma and not included in further analysis. Thirty-five episodes were managed with noninvasive ventilation. Patients required ventilation in 114 of the remaining 260 episodes (44%). Of the 260 episodes, 138 met our definition of hypercapnic respiratory failure. Both pH and Paco 2 criteria were required for inclusion. Therefore, some hypercapnic patients (Paco 2 Ͼ 50 mm Hg) were not included if their pH was Ͼ 7.35. Patients required intubation in 74 of the 138 hypercapnic episodes (54%). Of the remaining 122 nonhypercapnic episodes, patients required intubation in 40 cases (33%). The difference in intubation rate was signif- icant (p Ͻ 0.01, t test) using this initial separation. The remainder of this report will focus on the 138 hypercapnic episodes. Table 1 summarizes the baseline characteristics of the hypercapnic episodes, separated into patients who responded to medical therapy and those who required intubation. A total of 47 medically treated patients (45 men, 2 women) were treated for 64 episodes of hypercapnic respiratory failure, and 56 intubated patients (54 men, 2 women) accounted for 74 episodes of hypercapnic respiratory failure. It should be noted that eight patients (11 episodes) had previously established treatment preferences including do-not-intubate status; all of these patients were in the medically treated group. PFTs were available for 70% (33/47) of the medically treated patients and 63% (35/56) of the intubated patients, with no statistical difference between the two groups. The intubated patients did have a significantly higher APACHE II score (18 Ϯ 5 vs 16 Ϯ 4; p Ͻ 0.01, t test), signifying a greater severity of illness. 2 ) , and hypercapnic, with a Paco 2 Ͼ 70 mm Hg (52% vs 44%), although the latter two parameters were not statistically significant. These values are supportive of a greater severity of illness at presentation among those who eventually required intubation. On their initial CXRs, more of the intubated patients had infiltrates suggestive of pneumonia (27% vs 13%; p ϭ 0.057, 2 ), although this observation is tempered by the relatively small number of patients and nonsignificant p value.
The response to therapy is summarized in Table 3 . In medically treated patients, hypercapnic respiratory failure resolved in 35 Ϯ 30 h (range, 5 to 168 h). Patients who required intubation were intubated within 7 Ϯ 12 h (range, 0.25 to 72 h); the duration of intubation was 7 Ϯ 9 days (range, 1 to 60 days). The all-cause 30-day mortality was about the same in the medically treated group and intubated group (15% and 13%, respectively). Eight patients (11 episodes of hypercapnic respiratory failure) had advance directives requesting that they not be intubated; they were equally distributed among all four pH subgroups. Of these eight patients and 11 episodes, (Fig 1) , about half (52%) had resolution of their hypercapnic respiratory failure within 24 h; 80% experienced resolution within 48 h, and 92% within 72 h. Among intubated patients (Fig 2) , more than half (65%) were intubated within 4 h of presentation, 78% within 8 h, 86% within 12 h, and the vast majority (93%) within 24 h of presentation.
A further breakdown based on the initial degree of acidosis is presented in Tables 4, 5. Table 4 outlines the response in the medically treated patients. As might be expected, patients with a greater severity of respiratory acidosis required a longer time frame for resolution of their hypercapnic respiratory failure. This was most evident in those with an initial pH Յ 7.20. Patients with an initial pH of 7.21 to 7.25 required 36 Ϯ 29 h for resolution, although this was not significantly longer than the time to resolution in those with a pH of 7.31 to 7.35 (30 Ϯ 18 h). A more severe acidosis was also associated with a shorter time to intubation; time to intubation was 2 Ϯ 2 h for patients with a pH Յ 7.20, compared with 13 Ϯ 18 h for those with a pH between 7.31 and 7.35 (Table 5) . The time to intubation gradually increased with increasing pH, although these differences were not statistically significant (NS). Once patients were intubated, the duration of intubation did not differ based on the initial pH at the time of presentation. As might be expected, mortality rates were highest at the lowest pH group.
A further analysis was made of patients who required intubation. Patients in 49 of the 74 episodes had more than one ABG obtained prior to intubation. These patients had a longer course of therapy (10.2 Ϯ 13.4 h) prior to intubation than did patients in the other 25 episodes, in which intubation was performed within 0.8 h (range, 0.25 to 1.5 h) of presentation. This group of 49 underwent further analysis, with a focus on the last ABG obtained prior to intubation.
The changes in pH and Paco 2 prior to intubation are depicted in Figures 3, 4 . Worsening respiratory acidosis with increasing hypercapnia was the most common ABG pattern. Worsening hypercapnia was noted in 43 of 49 patients (88%), and worsening acidosis was seen in 39 of 49 patients (78%). Patients remained quite acidotic prior to intubation. In the six patients with improving hypercapnia, the average pH rose from 7.22 Ϯ 0.05 to 7.26 Ϯ 0.08; the average Paco 2 decreased from 81 Ϯ 19 mm Hg to 67 Ϯ 16 mm Hg. In the 10 patients with some improvement in their acidosis, the average pH increased from 7.21 Ϯ 0.08 to 7.28 Ϯ 0.07; the average Paco 2 decreased from 73 Ϯ 17 to 68 Ϯ 12 mm Hg. The magnitude of changes were small, and patients remained in respiratory distress despite therapy.
A further breakdown of the 39 patients with worsening acidosis who required intubation is presented in Table 6 . These patients had progression of their respiratory status with worsening acidosis and hypercapnia. From the aggregate data, the acidosis worsened in each subgroup prior to intubation. The severity of acidosis prior to intubation was worse in the most acidemic patients, with the range of the average preintubation pH being between 7.14 and 7.23. The absolute decline in pH was higher in those who had an initial pH between 7.31 and 7.35 (from 7.33 to 7.23, or 0.10) as compared with those who had an initial pH Յ 7.20 (from 7.17 to 7.14, or 0.03). The intubation rate was determined for each initial pH value and group of pH values in 0.05 increments. The intubation rate increased with worsening severity of acidosis. Visual inspection identified a threshold pH of 7.25. Patients were more likely to be intubated when the initial pH was 7.25, with an intubation rate consistently Ն 50%, whereas the rates were Ͻ 50% at higher initial pH levels. Figure 5 provides a summary of intubation rates for all patients (medically treated and intubated) based on their initial degree of acidosis. It is not surprising that the highest rate of intubation occurred in those with an initial pH Յ 7.20; in 70% of such episodes, patients eventually required intubation and mechanical ventilation. Among those with a pH Ͼ 7.25, less than half required intubation; this rate was not statistically different between the two subgroups.
Discussion
It is well recognized that many patients with COPD and hypercapnic respiratory failure may recover from their episode without intubation. This aspect of management has never been closely examined. Previous studies have focused on the mortality rate or intubation rate. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] From those studies, the severity of respiratory acidosis has been recognized as an important prognostic factor in COPD patients with respiratory failure. The more acidemic patients had a higher intubation and mortality rate. Kettel et al 3 identified a threshold pH of 7.23, while Warren et al 5 and Jeffrey et al 9 identified a pH of 7.26, below which increased mortality was noted.
The intubation rate has varied widely (from Ͻ 10% to 65%). There are some clear indications for intubation (eg, apnea or near apnea), with remaining conditions less well defined. These include speech dyspnea, abdominal paradox, altered mental status and need for airway protection, inability to clear secretions, as well as severe hypoxemia, hypercapnia, and respiratory acidosis. 18 -20 The relationship between respiratory acidosis and intubation has not been examined in detail. Sluiter and colleagues 2 reported intubation rates of 85% in patients with a pH Յ 7.20 and 63% in patients with a pH between 7.21 and 7.40 treated between 1966 and 1970. Seneff et al 11 reported on COPD patients with acute exacerbations identified in the APACHE III inception cohort study. This study focused on 362 admissions to 42 ICUs between May 1988 and February 1990. Intubated patients had longer ICU Table 6 -Changes in ABGs Prior to Intubation: Intubated Patients* and hospital stays and higher mortality when compared with nonintubated patients. Mortality was reviewed based on an initial Paco 2 Ն 50 mm Hg. There was no difference in immediate mortality rates, but an increased 1-year mortality rate for the hypercapnic group was noted. There was no analysis based on the initial level of respiratory acidosis. This study's intubation rate of 47% was comparable to our overall intubation rate of 44%.
None of the referenced studies have examined the time course of response (or lack of response) in COPD patients with hypercapnic respiratory failure. McNicholas and colleagues (McNally et al 15 and Costello et al 16 ) come closest in their reports of a group of hypercapnic patients with mild respiratory acidosis (pH, 7.34 Ϯ 0.06). In their series, 40% of patients reverted to normocapnia, with a steady decline in Paco 2 over a 2-week period. There was no information on correction of pH.
The main goal of the present study was to better characterize the response to current medical therapy of COPD patients with acute exacerbations and hypercapnic respiratory failure. Since the reports of the 1970s, therapy has evolved to include newer, more specific sympathomimetics, anticholinergic agents, and antibiotics, with newer drug delivery methods and changes in ventilator management. The time frame of this study (1990 to 1994) is different from that in past studies and reflective of current practice. Although our study population consisted primarily of elderly men, they are prototypical COPD patients.
Our results provide a framework of expected response for COPD patients in hypercapnic respiratory failure. Patients who required intubation presented with a greater severity of illness, as manifested by higher APACHE II scores, leukocytosis, and azotemia. A greater proportion of these intubated patients were more severely hypoxemic. Those who required intubation were usually intubated within 8 h of presentation (78%), and the vast majority (93%) within 24 h. Among patients successfully treated medically, about half (52%) required 24 h, and 80% required 48 h; the vast majority (92%) improved within 72 h.
Patients were separated into subgroups based on their initial pH for further analysis. From the data in Tables 4, 5 and Figure 5 , there is a clear difference in terms of intubation rate at a pH of 7.25. Only about half of the patients with a pH Ͼ 7.25 were intubated, with the percentage rising above 50% in the subgroups with a pH Յ 7.25; the rate was highest (70%) among those with a pH Ͻ 7.20. It follows that these more acidemic patients have a shorter time to intubation and longer time for resolution with medical therapy. Because most of the severely acidemic (pH Ͻ 7.20) patients were intubated within 2 Ϯ 2 h, this can serve as a guide to the time frame in which to expect some response or lack of response to therapy. It should be emphasized that acidemia is not the sole determinant of intubation, as 30% of the group with the lowest pH responded to medical management. Conversely, this information can also be used to continue treatment in less-acidemic patients with the goal of avoiding intubation.
A focus on the group of intubated patients with serial ABGs provides additional information. The vast majority of patients developed progressive hypercapnia and worsening acidosis prior to intubation. The severity of acidosis remains an important factor in the decision for intubation. As a single parameter, it provides insight to the patient's respiratory status. Worsening acidosis with hypercapnia provides objective support for ineffective alveolar ventilation, regardless of the underlying mechanism, and is often a prelude to frank respiratory failure and/or arrest. However, acidosis is not the sole determinant of intubation. Other conditions (breathing pattern, secretions, and/or impending failure) also influence the decision for intubation. These are more subjective factors not easily identified on retrospective review. This premise is further supported by the observation that worsening hypercapnia and acidosis were not universal in the intubated patients, occurring in 88% and 78% of those with serial ABGs (Fig 3, 4) .
Among patients who continued to worsen (Table  6 ), a lower pH was tolerated for the group who had a low initial pH (Յ 7.20) prior to intubation (mean pH, 7.14). In the other groups, patients were not intubated until their pH dipped below 7.25 (mean, 7.22 and 7.23) . This data provides additional support for the threshold pH of 7.25. A more precise characterization of the response to therapy, as well as validation of these observations, would require a prospective study.
This information would be useful given the increasing availability of noninvasive ventilation. This subset of patients was excluded in our analysis, as we wished to focus on the success or failure of medical therapy without the influence of noninvasive ventilation. Therefore, this group of 138 would reflect the response to "standard" therapy and provide a historical comparison group for current and future reports on noninvasive ventilation. Noninvasive ventilation is a relatively new modality, with indications and limitations not clearly established. The severity threshold for safe application of noninvasive ventilation has not been determined. Although most investigators do not specifically exclude patients from noninvasive ventilation based on pH, most enrollees have a pH Ͼ 7.25. [21] [22] [23] [24] In another analysis of noninvasive ventilation, a group of unsuccessfully treated patients had a pH of 7.22 Ϯ 0.08 compared with a pH of 7.28 Ϯ 0.04 in successfully treated patients. 25 Based on our experience and these reports, it appears that a threshold value of 7.25 can be used to identify patients who are more likely to be intubated and therefore less likely to respond to a trial of noninvasive ventilation. This information could be used to limit or omit a trial of medical therapy (including noninvasive ventilation) in the most severely ill patients, avoiding a delay in intubation.
Although this was a retrospective review subject to the uncertainties of all retrospective analyses, every effort was made to precisely identify key events. The computerized medical record allows an exact designation of time. Events such as intubation time were corroborated by several independent sources (nursing notes, procedure notes, ICU flow sheets, ABG times). This allowed precise calculation from the time of presentation to intubation (or resolution). There may be some uncertainty with the time to resolution, as this was defined by ABG values. Patients may have recovered to an acceptable baseline level for several hours prior to the ABG collection, and the error would lie in overestimating the time to resolution. Occasionally, this methodology may underestimate the time to resolution, but most physicians would consider patients to have recovered with resolution of their respiratory acidosis.
There may be concern that therapy was not uniform among all of these patients or that there were no explicit criteria for intubation. Although patients did not receive exactly the same treatment during this time period, all patients were treated in the same manner. They all received high-dose and frequent bronchodilator therapy, steroids, and antibiotics. Theophylline was used in equal proportion (about 40%) in both groups. Management can be considered reflective of medical practice in the early 1990s, and therefore differs from that reported in earlier studies. Although there are criteria for intubation, the decision to intubate has always required both clinical judgment and assessment of a patient's clinical status. It should be evident that the decision to intubate encompasses many factors and is not based on any single parameter or even a combination of parameters. Our overall intubation rate is similar to that reported in a recent multicenter database, 11 providing additional support that our experience is reflective of current management.
In summary, increasing severity of respiratory acidosis at initial presentation is associated with an increased likelihood of intubation. In patients with an initial pH of Ͻ 7.25, the intubation rate increased. In most medically treated patients, the respiratory acidosis will resolve within 48 h. Most patients who require intubation are intubated within 8 h of presentation. However, intubation is not universal, and even the subgroup of patients with the lowest pH can be managed medically. The breakdown by different pH levels of this report should provide added information on expectations based on the initial severity of respiratory acidosis. This, in turn, should help with the decision whether to treat patients medically, institute noninvasive ventilation, or proceed to intubation. This may be especially useful for those patients with very severe underlying lung disease in whom it would be worthwhile to proceed with a trial of aggressive therapy with the goal of avoiding intubation and prolonged mechanical ventilation.
